Regenxbio Aims For Big Chunk Of Retinal Disease Market With AbbVie-Partnered Gene Therapy

 
• By Alaric DeArment
  
Regenxbio announced interim results from the AAVIATE trial of its gene therapy for wet AMD • Source: Shutterstock

More from Clinical Trials

More from R&D